TrialNature medicine2026

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial.

Filip Ventorp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.